Sign in
4

Changes in Ownership

Dyne Therapeutics, Inc. Filed Acc 0001209191-23-050169

See Remarks sold 12,032 shares at $9.41 ($113,221)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Brumm Joshua T See Remarks 2023-09-18 Sale −12,032 $9.41 $113,221 233,679 D
Open-market sales · 12,032 sh · avg $9.41 · $113,221
Loading xslF345X05/doc4.xml…